TAKE Intrinsic Value
TAKE intrinsic value. TAKE (TAKE) median intrinsic value is ₹25.44 from 9 valuation models (range ₹7–₹32), vs current price ₹12.72 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit TAKE share price chart.
TAKE Valuation Methods Summary — DCF, Graham Number & P/E
TAKE intrinsic value across 9 models vs current price ₹12.72 — upside/downside and value range per method. Read TAKE dividend payments for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹25.52 | ₹20.42 - ₹30.62 | +100.6% | EPS: ₹1.16, Sector P/E: 22x |
| Book Value Method | asset | ₹31.80 | ₹28.62 - ₹34.98 | +150.0% | Book Value/Share: ₹20.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹25.44 | ₹22.90 - ₹27.98 | +100.0% | Revenue/Share: ₹157.33, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹25.44 | ₹22.90 - ₹27.98 | +100.0% | EBITDA: ₹16.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹31.80 | ₹25.44 - ₹38.16 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹7.42 | ₹6.68 - ₹8.16 | -41.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹17.92 | ₹16.13 - ₹19.71 | +40.9% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹25.44 | ₹22.90 - ₹27.98 | +100.0% | ROE: 51.6%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹23.22 | ₹20.90 - ₹25.54 | +82.5% | EPS: ₹1.16, BVPS: ₹20.67 |
TAKE Intrinsic Value vs Market Price — All Valuation Models
TAKE fair value range ₹7–₹32 vs current market price ₹12.72 across 9 valuation models. Compare with TAKE fair price to assess whether the stock is under or overvalued.
TAKE Intrinsic Value Analysis — Undervalued or Overvalued?
TAKE median intrinsic value ₹25.44, current price ₹12.72 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of TAKE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of TAKE (TAKE) is ₹25.44 (median value). With the current market price of ₹12.72, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹7.42 to ₹31.80, indicating ₹7.42 - ₹31.80.
Is TAKE undervalued or overvalued?
Based on our multi-method analysis, TAKE (TAKE) appears to be trading below calculated value by approximately 100.0%.
TAKE Financial Health — Key Ratios vs Industry Benchmarks
TAKE financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 51.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 6.56x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
TAKE Cash Flow Quality — Operating & Free Cash Flow
TAKE operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-16 Cr | ₹-16 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹9 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹20 Cr | ₹19 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹30 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |